Entity Common Stock, Shares Outstanding of Lunai Bioworks Inc. from 22 Nov 2011 to 11 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Lunai Bioworks Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 22 Nov 2011 to 11 Feb 2026.
  • Lunai Bioworks Inc. Entity Common Stock, Shares Outstanding for the quarter ending 11 Feb 2026 was 24,187,356, a 85% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Lunai Bioworks Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 24,187,356 -134,530,153 -85% 11 Feb 2026 10-Q 17 Feb 2026 2026 Q2
Q3 2025 231,802,470 +75,608,558 +48% 26 Sep 2025 10-K 29 Sep 2025 2025 FY
Q1 2025 172,118,569 +24,613,625 +17% 13 May 2025 10-Q 15 May 2025 2025 Q3
Q4 2024 158,717,509 +15,049,137 +10% 12 Feb 2025 10-Q 19 Feb 2025 2025 Q2
Q3 2024 156,193,912 +90,495,768 +138% 03 Oct 2024 10-K/A 19 Feb 2025 2024 FY
Q1 2024 147,504,944 +91,799,423 +165% 10 May 2024 10-Q/A 19 Feb 2025 2024 Q3
Q4 2023 143,668,372 14 Feb 2024 10-Q 14 Feb 2024 2024 Q2
Q3 2023 65,698,144 29 Sep 2023 10-K 02 Oct 2023 2023 FY
Q1 2023 55,705,521 +2,755,554 +5.2% 09 Mar 2023 10-Q 09 Mar 2023 2023 Q2
Q1 2022 52,949,967 +5,186,747 +11% 12 May 2022 10-Q 13 May 2022 2022 Q3
Q4 2021 52,633,267 14 Feb 2022 10-Q 14 Feb 2022 2022 Q2
Q3 2021 52,219,661 +5,582,685 +12% 24 Sep 2021 10-K 24 Sep 2021 2021 FY
Q2 2021 47,795,952 17 May 2021 10-Q 17 May 2021 2021 Q3
Q1 2021 47,763,220 +1,265,811 +2.7% 16 Feb 2021 10-Q 16 Feb 2021 2021 Q2
Q3 2020 46,636,976 +363,052 +0.78% 23 Sep 2020 10-K 23 Sep 2020 2020 FY
Q1 2020 46,497,409 11 May 2020 10-Q 11 May 2020 2020 Q3
Q4 2019 46,308,924 +7,519,614 +19% 10 Feb 2020 10-Q 10 Feb 2020 2020 Q2
Q3 2019 46,273,924 +10,100,000 +28% 27 Sep 2019 10-K 30 Sep 2019 2019 FY
Q2 2019 38,789,310 16 May 2019 10-Q 16 May 2019 2019 Q3
Q4 2018 38,789,310 +24,878,416 +179% 12 Feb 2019 10-Q 13 Feb 2019 2019 Q2
Q3 2018 36,173,924 +22,446,386 +164% 28 Sep 2018 10-K 01 Oct 2018 2018 FY
Q1 2018 36,163,924 +23,730,634 +191% 15 May 2018 10-Q 15 May 2018 2018 Q3
Q4 2017 13,910,894 +4,377,604 +46% 07 Feb 2018 10-Q 09 Feb 2018 2018 Q2
Q3 2017 13,727,538 +4,194,248 +44% 28 Sep 2017 10-K 29 Sep 2017 2017 FY
Q1 2017 12,433,290 +2,900,000 +30% 15 May 2017 10-Q 15 May 2017 2017 Q3
Q4 2016 9,533,290 0 0% 14 Feb 2017 10-Q 14 Feb 2017 2017 Q2
Q3 2016 9,533,290 0 0% 25 Sep 2016 10-K 28 Sep 2016 2016 FY
Q1 2016 9,533,290 0 0% 11 May 2016 10-Q 13 May 2016 2016 Q3
Q4 2015 9,533,290 12 Feb 2016 10-Q 12 Feb 2016 2016 Q2
Q3 2015 9,533,290 +458,500 +5.1% 15 Sep 2015 10-KT 28 Sep 2015 2015 FY
Q1 2015 9,533,290 +1,678,343 +21% 30 Mar 2015 10-K 31 Mar 2015 2014 FY
Q3 2014 9,074,790 11 Nov 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 8,040,000 +3,040,000 +61% 14 Aug 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 7,854,947 14 May 2014 10-Q 14 May 2014 2014 Q1
Q4 2013 5,000,000 0 0% 10 Feb 2014 10-Q 11 Feb 2014 2013 Q3
Q2 2013 5,000,000 0 0% 16 Jul 2013 10-K 16 Jul 2013 2012 FY
Q4 2012 5,000,000 0 0% 14 Feb 2013 10-Q 14 Feb 2013 2012 Q3
Q3 2012 5,000,000 20 Aug 2012 10-Q 20 Aug 2012 2012 Q1
Q2 2012 5,000,000 16 Jul 2012 10-K 17 Jul 2012 2011 FY
Q1 2012 5,000,000 21 Feb 2012 10-Q 21 Feb 2012 2011 Q3
Q4 2011 5,000,000 22 Nov 2011 10-Q 25 Nov 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.